Trends in the use of percutaneous ventricular assist devices: Analysis of National Inpatient Sample data, 2007 through 2012

JAMA Internal Medicine

Volumn 175, Issue 6, 2015, Pages 941-950

  Khera, Rohan ^a   Cram, Peter ^b,c   Lu, Xin ^a   Vyas, Ankur ^a   Gerke, Alicia ^a   Rosenthal, Gary E ^a   Horwitz, Phillip A ^a   Girotra, Saket ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AGED; ALCOHOLISM; ARTICLE; CARDIOGENIC SHOCK; CHRONIC KIDNEY DISEASE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRAAORTIC BALLOON PUMP; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; RETROSPECTIVE STUDY; UNITED STATES; VENTRICULAR ASSIST DEVICE; COMPARATIVE STUDY; HEART ASSIST DEVICE; MIDDLE AGED; TRENDS; UTILIZATION;

AGED; FEMALE; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84930743887     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.7856     Document Type: Article

References (33)

1. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117(5):686-697.
2. Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation. 2012;125(14):1809-1817.
3. Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock.Eur Heart J. 2014;35(3):156-167.
4. Levine GN, Bates ER, Blankenship JC, et al American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44-e122.
5. O'Gara PT, Kushner FG, Ascheim DD, et al American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4): e362-e425.
6. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52 (19):1584-1588.
7. Shah NR, Bieniarz MC, Basra SS, et al. Serum biomarkers in severe refractory cardiogenic shock. JACC Heart Fail. 2013;1(3):200-206.
8. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30(17):2102-2108.
9. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469.e1-469.e8.
10. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276-1283.
11. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717-1727.
12. Healthcare Cost and Utilization Project (HCUP). Overview of the National (Nationwide) Inpatient Sample (NIS). Rockville, MD: Agency for Healthcare Research and Quality. July 2014. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed October 24, 2014.
13. Houchens RL, Ross DN, Elixhauser A, Jiang J. Nationwide Inpatient Sample Redesign: Final Report. April 4, 2014. https://www.hcup-us.ahrq.gov/db/nation/nis/reports/NISRedesignFinalReport040914.pdf. Accessed July 20, 2014.
14. HCUP. Trend Weights for HCUP NIS Data. Rockville, MD: Agency for Healthcare Research and Quality. September 2014. http://www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp. Accessed July 20, 2014.
15. HCUP. HCUP National Estimates. Rockville, MD: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/tech-assist/nationalestimates/508-course/508course.htm. Accessed October 24, 2014.
16. US Bureau of Labor Statistics. CPI inflation calculator. http://www.bls.gov/data/inflation-calculator.htm. 2014. Accessed May 30, 2014.
17. Houchens R, Elixhauser A. Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001. HCUP Method Series Report 2003-02. Rockville, MD: Agency for Healthcare Research and Quality. June 2005. http://www.hcup-us.ahrq.gov/reports/methods/CalculatingNISVariances200106092005.pdf. Accessed May 13, 2014.
18. Bland JM, Altman DG. Transformations, means, and confidence intervals. BMJ. 1996;312(7038):1079.
19. Dugoff EH, Schuler M, Stuart EA. Generalizing observational study results: applying propensity score methods to complex surveys. Health Serv Res. 2014;49(1):284-303.
20. Feng W, Jun Y, Xu R. A method/macro based on propensity score and Mahalanobis distance to reduce bias in treatment comparison in observational study. Paper presented at: SAS PharmaSUG 2006 Conference; May 22, 2006; Bonita Springs, Florida.
21. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I Trial): initial US experience. JACC Cardiovasc Interv. 2009;2(2):91-96.
22. Thiele H, Zeymer U, Neumann FJ, et al; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14): 1287-1296.
23. Perera D, Stables R, Clayton T, et al; BCIS-1 Investigators. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013;127(2):207-212.
24. Food and Drug Administration. Warning Letter: Abiomed. June 10, 2011. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm260341.htm. Accessed July 20, 2014.
25. MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial Infarction. http://clinicaltrials.gov/show/NCT01319760. Accessed June 24, 2014.
26. Yu D. TCT 2011: Cost-effectiveness data and society guidelines shed new light on Abiomed's Impella 2.5. The Advisory Board Company website. November 14, 2011. http://www.advisory.com/Research/Service-Line-Strategy-Advisor/the-pipeline/2011/11/tct-2011-cost-effectiveness-data-and-society-guidelines-shed-new-light-on-abiomeds-impella-25. Accessed October 23, 2014.
27. Curfman GD, Redberg RF. Medical devices - balancing regulation and innovation. N Engl J Med. 2011;365(11):975-977.
28. Challoner DR, Vodra WW. Medical devices and health - creating a new regulatory framework for moderate-risk devices. N Engl J Med. 2011;365(11): 977-979.
29. Food and Drug Administration. 510(k) Premarket Notification: K991783. 2000. http: //www.accessdata.fda.gov/cdrh-docs/pdf/K991783.pdf. Accessed October 20, 2014.
30. Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years. Washington, DC: National Academies Press; 2011.
31. th Global Patient Milestone [press release]. Abiomed website. August 2, 2013. http://investors.abiomed.com/releasedetail.cfm?ReleaseID=782468. Accessed June 24, 2014.
32. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155-2165.
33. Sjauw KD, Konorza T, Erbel R, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device: the Europella registry. JAm Coll Cardiol. 2009;54(25):2430-2434.